SE511237C2 - Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor - Google Patents

Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor

Info

Publication number: SE511237C2
Authority: SE; Sweden
Prior art keywords: astaxanthin; human; mothers; mastitis; type
Prior art date: 1997-12-16

Application number

SE9704693A

Other languages

English (en)

Swedish (sv)

Other versions

SE9704693L (sv

SE9704693D0 (sv

Inventor

Aake Lignell

Johan Inborr

Original Assignee

Astacarotene Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-16

Filing date

1997-12-16

Publication date

1999-08-30

1997-12-16 Application filed by Astacarotene Ab filed Critical Astacarotene Ab

1997-12-16 Priority to SE9704693A priority Critical patent/SE511237C2/sv

1997-12-16 Publication of SE9704693D0 publication Critical patent/SE9704693D0/xx

1998-12-10 Priority to NZ504801A priority patent/NZ504801A/en

1998-12-10 Priority to DE69814467T priority patent/DE69814467D1/de

1998-12-10 Priority to JP2000538684A priority patent/JP2002508318A/ja

1998-12-10 Priority to EP98963702A priority patent/EP1049460B1/de

1998-12-10 Priority to AT98963702T priority patent/ATE239457T1/de

1998-12-10 Priority to AU18972/99A priority patent/AU743198B2/en

1998-12-10 Priority to PCT/SE1998/002279 priority patent/WO1999030701A1/en

1998-12-10 Priority to CA002314170A priority patent/CA2314170C/en

1998-12-10 Priority to US09/589,594 priority patent/US6335015B1/en

1998-12-16 Priority to ARP980106418A priority patent/AR017877A1/es

1999-06-17 Publication of SE9704693L publication Critical patent/SE9704693L/

1999-08-30 Publication of SE511237C2 publication Critical patent/SE511237C2/sv

2000-06-14 Priority to NO20003042A priority patent/NO327301B1/no

Links

235000008210 xanthophylls Nutrition 0.000 title claims abstract description 12
208000004396 mastitis Diseases 0.000 title claims abstract description 8
238000002360 preparation method Methods 0.000 title claims abstract description 5
238000011321 prophylaxis Methods 0.000 title claims abstract description 5
KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 title claims description 8
229960005375 lutein Drugs 0.000 title claims description 8
KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 title claims description 8
FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 title claims description 8
239000000273 veterinary drug Substances 0.000 title 1
JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 27
235000013793 astaxanthin Nutrition 0.000 claims abstract description 27
MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 27
229940022405 astaxanthin Drugs 0.000 claims abstract description 27
239000001168 astaxanthin Substances 0.000 claims abstract description 27
241000195493 Cryptophyta Species 0.000 claims abstract description 6
241000168525 Haematococcus Species 0.000 claims abstract description 6
235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 5
229930195729 fatty acid Natural products 0.000 claims abstract description 5
239000000194 fatty acid Substances 0.000 claims abstract description 5
150000004665 fatty acids Chemical class 0.000 claims abstract description 5
238000012258 culturing Methods 0.000 claims abstract description 4
229940126601 medicinal product Drugs 0.000 claims description 5
238000004519 manufacturing process Methods 0.000 claims description 4
230000037396 body weight Effects 0.000 claims description 3
235000013312 flour Nutrition 0.000 claims description 2
239000003814 drug Substances 0.000 abstract description 4
150000003735 xanthophylls Chemical class 0.000 abstract description 4
235000012054 meals Nutrition 0.000 abstract description 3
238000000034 method Methods 0.000 abstract description 3
-1 astaxanthin Chemical class 0.000 abstract 2
241000283690 Bos taurus Species 0.000 description 3
235000013365 dairy product Nutrition 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
235000013305 food Nutrition 0.000 description 2
230000006651 lactation Effects 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
239000000203 mixture Substances 0.000 description 2
241000238424 Crustacea Species 0.000 description 1
241000233866 Fungi Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
239000000969 carrier Substances 0.000 description 1
235000019219 chocolate Nutrition 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
238000013401 experimental design Methods 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
235000013618 yogurt Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Reproductive Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Oncology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Pregnancy & Childbirth (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)

SE9704693A 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor SE511237C2 (sv)

Priority Applications (12)

Application Number	Priority Date	Filing Date	Title
SE9704693A SE511237C2 (sv)	1997-12-16	1997-12-16	Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor
US09/589,594 US6335015B1 (en)	1997-12-16	1998-12-10	Method of the prophylactic treatment of mastitis
AU18972/99A AU743198B2 (en)	1997-12-16	1998-12-10	Method of the prophylactic treatment of mastitis
DE69814467T DE69814467D1 (de)	1997-12-16	1998-12-10	Verfahren zur prophylaktischen behandlung von mastitis
JP2000538684A JP2002508318A (ja)	1997-12-16	1998-12-10	乳腺炎の予防処置法
EP98963702A EP1049460B1 (de)	1997-12-16	1998-12-10	Verfahren zur prophylaktischen behandlung von mastitis
AT98963702T ATE239457T1 (de)	1997-12-16	1998-12-10	Verfahren zur prophylaktischen behandlung von mastitis
NZ504801A NZ504801A (en)	1997-12-16	1998-12-10	A medicament containing one type of xanthophylis for the prophylactic treatment of mastitis
PCT/SE1998/002279 WO1999030701A1 (en)	1997-12-16	1998-12-10	Method of the prophylactic treatment of mastitis
CA002314170A CA2314170C (en)	1997-12-16	1998-12-10	Method of the prophylactic treatment of mastitis
ARP980106418A AR017877A1 (es)	1997-12-16	1998-12-16	Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo
NO20003042A NO327301B1 (no)	1997-12-16	2000-06-14	Anvendelse av astaxanthin for fremstilling av et medikament til behandling av mastitt

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9704693A SE511237C2 (sv)	1997-12-16	1997-12-16	Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor

Publications (3)

Publication Number	Publication Date
SE9704693D0 SE9704693D0 (sv)	1997-12-16
SE9704693L SE9704693L (sv)	1999-06-17
SE511237C2 true SE511237C2 (sv)	1999-08-30

Family

ID=20409414

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9704693A SE511237C2 (sv)	1997-12-16	1997-12-16	Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor

Country Status (12)

Country	Link
US (1)	US6335015B1 (de)
EP (1)	EP1049460B1 (de)
JP (1)	JP2002508318A (de)
AR (1)	AR017877A1 (de)
AT (1)	ATE239457T1 (de)
AU (1)	AU743198B2 (de)
CA (1)	CA2314170C (de)
DE (1)	DE69814467D1 (de)
NO (1)	NO327301B1 (de)
NZ (1)	NZ504801A (de)
SE (1)	SE511237C2 (de)
WO (1)	WO1999030701A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9903336D0 (sv) *	1999-09-17	1999-09-17	Astacarotene Ab	DNA construct and its use
SE9903619D0 (sv) *	1999-10-07	1999-10-07	Astacarotene Ab	Use and method of treatment
US7521584B2 (en)	2002-07-29	2009-04-21	Cardax Pharmaceuticals, Inc.	Carotenoid analogs or derivatives for the inhibition and amelioration of disease
US7145025B2 (en) *	2002-07-29	2006-12-05	Hawaii Biotech, Inc.	Structural carotenoid analogs for the inhibition and amelioration of disease
US20050059635A1 (en) *	2002-07-29	2005-03-17	Lockwood Samuel Fournier	Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US20050143475A1 (en) *	2002-07-29	2005-06-30	Lockwood Samuel F.	Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7320997B2 (en)	2002-07-29	2008-01-22	Cardax Pharmaceuticals, Inc.	Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US7723327B2 (en)	2002-07-29	2010-05-25	Cardax Pharmaceuticals, Inc.	Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7345091B2 (en)	2002-07-29	2008-03-18	Cardax Pharmaceuticals, Inc.	Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7375133B2 (en) *	2002-07-29	2008-05-20	Cardax Pharmaceuticals, Inc.	Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7763649B2 (en)	2002-07-29	2010-07-27	Cardax Pharmaceuticals, Inc.	Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050148517A1 (en) *	2002-07-29	2005-07-07	Lockwood Samuel F.	Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US20060058269A1 (en) *	2004-04-14	2006-03-16	Lockwood Samuel F	Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2005102356A1 (en) *	2004-04-14	2005-11-03	Hawaii Biotech, Inc.	Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
MX2007003773A (es)	2004-09-28	2009-01-19	Chemaphor Inc	Composiciones y metodos para promover ganancia de peso y conversion de alimentacion.
WO2006039685A2 (en) *	2004-10-01	2006-04-13	Hawaii Biotech, Inc.	Methods for synthesis of chiral intermediates of carotenoids, carotenoid analogs, and carotenoid derivatives
DK2214656T3 (en)	2007-10-26	2019-03-25	Avivagen Inc	COMPOSITIONS AND PROCEDURES TO ENHANCE IMMUNE RESPONSE
WO2010124392A1 (en) *	2009-04-30	2010-11-04	Chemaphor Inc.	Methods, compositions, and kits for the treatment of inflammatory conditions
US10456369B2 (en)	2009-04-30	2019-10-29	Avivagen Inc.	Methods and compositions for improving the health of animals
US20230079333A1 (en) *	2020-02-18	2023-03-16	Avivagen Inc.	Supplemented animal feeds for mammals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2619491B2 (ja)	1988-08-11	1997-06-11	サントリー株式会社	アスタキサンチン含有組成物
CA2210957A1 (en) *	1995-02-03	1996-08-08	Basf Aktiengesellschaft	The use of carotenoids for producing drugs for the treatment of dermatoses
JPH09124470A (ja)	1995-10-26	1997-05-13	Suntory Ltd	抗ストレス組成物
SE506191C2 (sv)	1996-03-27	1997-11-17	Astacarotene Ab	Medel och sätt för att öka produktionen av/hos däggdjur

1997
- 1997-12-16 SE SE9704693A patent/SE511237C2/sv not_active IP Right Cessation
1998
- 1998-12-10 WO PCT/SE1998/002279 patent/WO1999030701A1/en not_active Ceased
- 1998-12-10 JP JP2000538684A patent/JP2002508318A/ja active Pending
- 1998-12-10 AT AT98963702T patent/ATE239457T1/de not_active IP Right Cessation
- 1998-12-10 CA CA002314170A patent/CA2314170C/en not_active Expired - Fee Related
- 1998-12-10 US US09/589,594 patent/US6335015B1/en not_active Expired - Lifetime
- 1998-12-10 DE DE69814467T patent/DE69814467D1/de not_active Expired - Lifetime
- 1998-12-10 EP EP98963702A patent/EP1049460B1/de not_active Expired - Lifetime
- 1998-12-10 AU AU18972/99A patent/AU743198B2/en not_active Ceased
- 1998-12-10 NZ NZ504801A patent/NZ504801A/en not_active IP Right Cessation
- 1998-12-16 AR ARP980106418A patent/AR017877A1/es unknown
2000
- 2000-06-14 NO NO20003042A patent/NO327301B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1049460B1 (de)	2003-05-07
SE9704693L (sv)	1999-06-17
US6335015B1 (en)	2002-01-01
NO327301B1 (no)	2009-06-02
SE9704693D0 (sv)	1997-12-16
CA2314170A1 (en)	1999-06-24
NZ504801A (en)	2002-05-31
AU743198B2 (en)	2002-01-24
NO20003042L (no)	2000-06-14
DE69814467D1 (de)	2003-06-12
JP2002508318A (ja)	2002-03-19
CA2314170C (en)	2008-01-29
AR017877A1 (es)	2001-10-24
NO20003042D0 (no)	2000-06-14
ATE239457T1 (de)	2003-05-15
EP1049460A1 (de)	2000-11-08
AU1897299A (en)	1999-07-05
WO1999030701A1 (en)	1999-06-24

Legal Events

Date	Code	Title	Description
2018-01-30	NUG	Patent has lapsed

Publication	Publication Date	Title
EP0559425B1 (de)	1999-01-07	Verwendung von Proteinen der Transferrin/Lactoferrin-Familie zur Stimulation des Immunsystems
AU743198B2 (en)	2002-01-24	Method of the prophylactic treatment of mastitis
US11806375B2 (en)	2023-11-07	Nutritional support for animals via administration of an algal derived supplement
BG62757B1 (bg)	2000-07-31	Фармацевтични състави на основата на растителни етерични масла за хуманната и ветеринарната медицина
SE512531C2 (sv)	2000-03-27	Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur
EP1655292B1 (de)	2015-04-29	Präventive bzw. therapeutische zusammensetzung gegen virale infektionskrankheiten
Bazekin et al.	2021	The Effect of New Immunostimulants of Tissue and Plant Origin on the Morphological Characteristics of the Immune System's Central Organs and the Dynamics of Serum Immunoglobulins
US11612629B2 (en)	2023-03-28	Pharmaceutical composition for preventing or treating muscle diseases, containing ginseng berry extract as active ingredient
KR101260250B1 (ko)	2013-05-03	패모 추출물을 포함하는 항 호흡기 바이러스용 조성물
US6475547B1 (en)	2002-11-05	Immunoglobulin-rich milk, production and use thereof
SE513186C2 (sv)	2000-07-24	Sätt att öka produktionen av och förbättra kvaliteten hos sperma med användning av xantofyller
JP2009269832A (ja)	2009-11-19	カルシトニン遺伝子関連ペプチド及びインスリン様成長因子−１の産生促進組成物
WO2002038146A1 (en)	2002-05-16	Mucosal immunomodulator and use thereof
SE524337C2 (sv)	2004-07-27	Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
JPS5925769B2 (ja)	1984-06-21	動物薬組成物ならびにその製法
JP6280356B2 (ja)	2018-02-14	育毛・発毛促進用経口剤
Semba	2001	The vitamin A and mortality paradigm: past, present, and future
KR101728094B1 (ko)	2017-04-18	개머루덩굴 추출물 또는 이의 분획물을 유효성분으로 포함하는 바이러스성 질환 및 암의 예방 또는 치료용 약학적 조성물
KR20190085761A (ko)	2019-07-19	맥주효모를　유효성분으로 하는　면역증진　및　항염효과 증진용　복합추출 조성물
CN106474163B (zh)	2019-12-06	牛樟芝子实体萃取组合物的用途
JP2024061593A (ja)	2024-05-07	インターロイキン－１２産生促進剤
JP2023119096A (ja)	2023-08-28	間葉系細胞活性化剤、創傷治療剤、間葉系細胞活性化用経口組成物及び創傷治療用経口組成物
RU1669100C (ru)	1993-10-15	Способ выращивани птиц
Akubueze et al.	0	JOURNAL OF VETERINARY AND APPLIED SCIENCES
JP2008038011A (ja)	2008-02-21	高純度リン脂質の製造法